Viewing Study NCT05988034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-06-25 @ 10:47 PM
Study NCT ID: NCT05988034
Status: COMPLETED
Last Update Posted: 2023-08-14
First Post: 2023-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Electrocardiography View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Complement 5a receptor (C5aR) View
None Anti-neutrophil cytoplasmic antibody-associated vasculitis View
None Complement View
None Vasculitis View